Page last updated: 2024-11-05

tolbutamide and Head and Neck Neoplasms

tolbutamide has been researched along with Head and Neck Neoplasms in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)

Research Excerpts

ExcerptRelevanceReference
"Normal-weight and underweight cancer patients had a 32% to 44% reduction in insulin sensitivity (P < ."1.30Insulin secretion, glucose production, and insulin sensitivity in underweight and normal-weight volunteers, and in underweight and normal-weight cancer patients: a Clinical Research Center study. ( Abemayor, E; Manglik, S; Tayek, JA, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tayek, JA1
Manglik, S1
Abemayor, E1

Other Studies

1 other study available for tolbutamide and Head and Neck Neoplasms

ArticleYear
Insulin secretion, glucose production, and insulin sensitivity in underweight and normal-weight volunteers, and in underweight and normal-weight cancer patients: a Clinical Research Center study.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:2

    Topics: Anthropometry; Blood Glucose; Body Weight; Glucose Tolerance Test; Head and Neck Neoplasms; Humans;

1997